XOVR ERShares Private-Public Crossover ETF

Expense Ratio
1.81%
Previous close
$19.17
Est. 12 months change
-9.60%
Projected Price
$17.33

Profitability Metrics

Return on Equity (ROE)
40.98%
Return on Assets (ROA)
12.11%
Return on Invested Capital (ROIC)
54.27%
Weighted Average Cost of Capital (WACC)
13.72%
ROIC - WACC
40.55%
Updated : 2026-05-18 21:02 ET

Valuation Metrics

P/E Ratio
9.84
Forward P/E
26.24
PEG Ratio
6.59
Debt Current Ratio
3.65

Growth & Cash Flow

Gross Margin
49.91%
Operating Margin
-28.25%
FCF Margin
30.34%
TTM Revenue Growth
27.03%
Projected 12M EPS Growth
-62.49%

Price Change

Price % from 50 SMA
7.09%
Price % from 200 SMA
-1.08%
6 Months
-2.09%
1 Year
5.56%
2 Years
25.46%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NA18.41%
NVDA11.95%
GOOGL7.82%
META5.24%
APP3.97%
ALAB3.93%
RKLB3.49%
HOOD3.06%
VEEV2.97%
NTRA2.87%

ETF Analysis

Fund Overview

ERShares Private-Public Crossover ETF (XOVR) currently reports 30 stock positions (subject to change), placing it in the diversified without being diffuse range by holdings breadth. The top line-up is NA (18.41%), NVDA (11.95%), GOOGL (7.82%), with NA as the largest single weight at 18.41%. Together, the top three holdings account for 38.18%, which represents a dominant share and increases sensitivity to the performance of a narrow leadership group. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.

Profitability & Capital Efficiency

On a capital return basis, ROIC is 54.27%, WACC is 13.72%, and the economic spread is 40.55%. On balance, the portfolio's businesses are compounding at rates that meaningfully exceed what capital costs would otherwise allow. Supporting metrics show ROE at 40.98% and ROA at 12.11%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

On an earnings multiple basis, trailing P/E of 9.84, forward P/E of 26.24, PEG of 6.59. The gap between trailing and forward multiples is not especially wide, suggesting the market is pricing a steadier earnings path rather than a sharp near-term re-rating. The PEG ratio is elevated, suggesting investors are paying a premium for the growth embedded in current earnings estimates. A current ratio of 3.65 across the holding set reflects strong short-term liquidity. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Stripping to unit economics, gross margin sits at 49.91%, operating margin at -28.25%, and free cash flow margin at 30.34%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. At this operating margin level, businesses are generating little to no earnings after overhead — a sign of early-stage or high-investment dynamics. The portfolio's free cash flow margin is exceptional, pointing to capital-light businesses with strong reinvestment optionality. Across the three margin layers, the picture is inconsistent — a reminder that aggregate metrics can mask meaningful variation at the individual holding level.

Growth & Forward Outlook

Connecting operational trends with market expectations, TTM revenue growth of 27.03% indicating strong organic momentum at the portfolio level, while the estimated 12-month price change of -9.70%, where consensus targets point to downside risk over the next 12 months. At -62.5%, the projected 12-month EPS growth is a notable negative — it suggests earnings headwinds are building, a dynamic that usually invites multiple compression rather than expansion. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Hold

The balance of evidence suggests a neutral posture is appropriate — there are merits here, but also reasons for caution that limit conviction at current levels.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.